약가 |
품명(8) |
회사 |
약품동등 |
244,877 (2023-12-01) |
셀트리온유플라이마펜주40mg/0.4mL(아달리무맙,유전자재조합)_(40mg/0.4mL) 0.4mL/펜 |
셀트리온 |
|
244,877 (2023-06-01) |
아달로체펜주40mg/0.4mL(아달리무맙,유전자재조합)_(40mg/0.4mL) 0.4mL/펜 |
삼성바이오에피스 |
|
244,877 (2023-06-01) |
아달로체프리필드시린지주40mg/0.4mL(아달리무맙,유전자재조합)_(40mg/0.4mL) 0.4mL/관 |
삼성바이오에피스 |
|
244,508 (2024-07-01) |
유플라이마펜주40mg/0.4mL(아달리무맙,유전자재조합)_(40mg/0.4mL) 0.4mL/관 |
셀트리온 |
|
220,390 (2024-07-01) |
젤렌카오토인젝터주40mg/0.4mL(아달리무맙,유전자재조합)_(40mg/0.4mL) 0.4mL/펜 |
엘지화학 |
|
220,390 (2024-07-01) |
젤렌카프리필드시린지주40mg/0.4mL(아달리무맙,유전자재조합)_(40mg/0.4mL) 0.4mL/관 |
엘지화학 |
|
286,401 (2024-07-01) |
휴미라펜주40mg/0.4mL(아달리무맙,유전자재조합)_(40mg/0.4mL) 0.4mL/펜 |
한국애브비 |
|
286,401 (2024-07-01) |
휴미라프리필드시린지주40mg/0.4mL(아달리무맙,유전자재조합)_(40mg/0.4mL) 0.4mL/관 |
한국애브비 |
|